Michael Var­ney comes out of brief Genen­tech 're­tire­men­t' for R&D gig at Eras­ca; Vivek Ra­maswamy's Im­muno­vant re­cruits J&J vet for CSO post

→ Michael Var­ney is open­ing up a new chap­ter in his ca­reer af­ter step­ping down re­cent­ly from a high-pro­file job as head of re­search and ear­ly de­vel­op­ment at Roche’s pres­ti­gious gRED or­ga­ni­za­tion in South San Fran­cis­co.

He’s tak­en a job as chair­man of R&D at Eras­ca, a pri­vate biotech com­pa­ny that re­cent­ly raised a whop­ping $200 mil­lion from a syn­di­cate led by ARCH and Cor­morant. Eras­ca is led by Jonathan Lim, who sold Igny­ta to Roche for $1.7 bil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.